Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196.HK) released earnings for its nine months that Increased, from the same period last year
The company's earnings came in at RMB2.523 billion, or RMB0.95 per share. This compares with RMB2.010 billion, or RMB0.75 per share, last year.
The company's revenue for the period fell 4.9% to RMB29.393 billion from RMB30.911 billion last year.
Shanghai Fosun Pharmaceutical (Group) Co Ltd earnings at a glance (GAAP) :
-Earnings: RMB2.523 Bln. vs. RMB2.010 Bln. last year.-EPS: RMB0.95 vs. RMB0.75 last year.-Revenue: RMB29.393 Bln vs. RMB30.911 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.